MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
Aethlon Medical Retained Earnings 2011-2026 | AEMD
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -168 M | -155 M | -142 M | -130 M | -120 M | -112 M | -106 M | -99.5 M | -93.8 M | -86.5 M | -81.6 M | -74.8 M | -61.5 M | -56.6 M | -48.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -48.5 M | -168 M | -102 M |
Quarterly Retained Earnings Aethlon Medical
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -173 M | -171 M | -170 M | -168 M | -162 M | -160 M | -157 M | -155 M | -152 M | -149 M | -146 M | -142 M | -140 M | -137 M | -133 M | -130 M | -127 M | -124 M | -122 M | -120 M | -118 M | -115 M | -113 M | -112 M | -110 M | -109 M | -108 M | -106 M | -104 M | -102 M | -101 M | -99.5 M | -98.1 M | -96.9 M | -95.6 M | -93.8 M | -92.1 M | -90.9 M | -88.6 M | -86.5 M | -85.3 M | -84 M | -82.8 M | -81.6 M | -80.7 M | -79.3 M | -78.5 M | -74.8 M | -67.2 M | -65.1 M | -61.8 M | -61.5 M | -58.7 M | -59 M | -57.6 M | -56.6 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -56.6 M | -173 M | -109 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
21.2 M | $ 25.45 | 1.37 % | $ 215 M |  USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.03 | 2.53 % | $ 1.23 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.89 | -1.49 % | $ 1.74 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 58.78 | -0.24 % | $ 3.21 B |  Britain |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.31 | -1.49 % | $ 124 M |  France |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 169.27 | 5.78 % | $ 11.9 B | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 10.9 | 5.42 % | $ 309 M | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.04 | 2.51 % | $ 5.66 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.62 | -2.04 % | $ 38.6 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 316.6 | 0.47 % | $ 121 B | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 22.86 | 1.58 % | $ 523 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.91 | 5.66 % | $ 42.7 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 18.95 | 4.38 % | $ 1.29 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.06 | 2.43 % | $ 18 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 14.75 | 0.75 % | $ 346 M | USA |
 |
Varex Imaging Corporation
VREX
|
-5.9 M | $ 11.37 | 3.08 % | $ 471 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.53 | -7.93 % | $ 959 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Vivos Therapeutics
VVOS
|
-125 M | $ 0.84 | 7.34 % | $ 8.63 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 89.35 | 1.78 % | $ 12.1 B | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.3 | 0.88 % | $ 369 M | USA |
 |
PAVmed
PAVM
|
-259 M | $ 8.65 | -3.03 % | $ 5.8 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 37.1 | 3.17 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 53.24 | -0.33 % | $ 1.56 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 87.27 | 4.3 % | $ 3.03 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 81.74 | 0.64 % | $ 47.8 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |